Active Ingredient: Lanreotide
Lanreotide is indicated for the treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumours.
For this indication, competent medicine agencies globally authorize below treatments:
For:
Subcutaneous, between 60 milligrams lanreotide and 120 milligrams lanreotide, once every 28 days. The maximum allowed total dose is 120 milligrams lanreotide every 28 days.
The recommended starting dose is 60 to 120 mg administered every 28 days.
The dose should be adjusted according to the degree of symptomatic relief obtained.
Lanreotide is administered by deep subcutaneous injection in the superior external quadrant of the buttock or in the upper outer thigh.
For patients who receive a stable dose of lanreotide, and after appropriate training, the injection may be administered either by the patient or by a trained person. In case of self-injection, the injection should be given in the upper outer thigh.
The decision regarding administration by the patient or a trained person should be taken by a healthcare professional.
Regardless of the injection site, the skin should not be folded and the needle should be inserted rapidly and to its full length, perpendicularly to the skin.
The injection site should alternate between the right and left side.
For:
Regimen A :
Intramuscular, 30 milligrams lanreotide, once every 14 days.
Regimen B, in the case that there is absent response to treatment :
Intramuscular, 30 milligrams lanreotide, once every 14 days. Afterwards, intramuscular, 30 milligrams lanreotide, once every 7 to 10 days.
Initially, one intramuscular injection of 30 mg should be given every 14 days. The frequency of subsequent injections may be varied in accordance with the individual patient's response (as judged by a reduction in symptoms and/or a reduction in GH and/or IGF-1 levels) such that injections can be given every 7 to 10 days as necessary.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.